2-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-8-ethyl-3-methyl-N,N-dipropylquinolin-5-amine | 1395411-62-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-8-ethyl-3-methyl-N,N-dipropylquinolin-5-amine
• CAS: 1395411-62-7
• 化学式: C₂₈H₃₈N₂O₃
• 分子量: 450.621
• InChiKey: MAPITVFZBHZWOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  33
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  43.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-3-methylquinolin-5-amine 在 N-碘代丁二酰亚胺 、 二(三叔丁基膦)钯 、 2-甲基吡啶-N-甲硼烷 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-8-ethyl-3-methyl-N,N-dipropylquinolin-5-amine
  参考文献：
  名称：

  Design, synthesis, and structure–activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists

  摘要：

  We designed and synthesized a series of 2-Ar-8-methyl-5-alkylaminolquinolines as potent corticotropin-releasing factor 1 (CRF1) receptor antagonists. The structure-activity relationships of substituents at each position (R-3, R-5, R-5', and R-8) was investigated. By derivatization, three compounds (6, 14b, and 14c) were identified as orally active CRF1 receptor antagonists. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.07.047

文献信息

• Design, synthesis, and structure–activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF1 receptor antagonists
  作者：Kunitoshi Takeda、Taro Terauchi、Minako Hashizume、Kogyoku Shin、Mitsuhiro Ino、Hisashi Shibata、Masahiro Yonaga

  DOI：10.1016/j.bmcl.2012.07.047

  日期：2012.9

  We designed and synthesized a series of 2-Ar-8-methyl-5-alkylaminolquinolines as potent corticotropin-releasing factor 1 (CRF1) receptor antagonists. The structure-activity relationships of substituents at each position (R-3, R-5, R-5', and R-8) was investigated. By derivatization, three compounds (6, 14b, and 14c) were identified as orally active CRF1 receptor antagonists. (C) 2012 Elsevier Ltd. All rights reserved.